Synapse: Law for Life Sciences





Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Planning for Brexit - find out what your need to know for your business
View our Global IP Index map and compare IP regimes around the world
Taylor Wessing launches the Taylor Wessing Patent Map
The Unified Patent Court guide
Subscribe to Synapse

The Treatment - A guide for life sceinces companies coming to Europe


On 3 October 2016, Taylor Wessing’s International Life Sciences Group launched The Treatment – A guide for life sciences companies coming to Europe. This unique publication is designed to provide a high level overview of the most important issues that should be considered for any life sciences company wishing to do business in Europe. It represents a distillation of our International Life Sciences Group's many years of experience in helping life sciences companies to do business in Europe and to thrive there.



arrowView our previous articles

Topical Issues


Advocate General Sharpston consider notified bodies may be liable to patients using medical devices

Tasmina Goraya discusses Advocate General Sharpston's Opinion to the Court of Justice of the European Union on the liability and obligations of Notified Bodies under the Medical Devices Directive in Elisabeth Schmitt v TÜV Rheinland LGA Products GmbH. read more


Three exclusivity rights to watch during Brexit

Paul England examines the potential impacts of Brexit on SPCs, paediatric extensions to SPCs and market exclusivity for orphan medicinal products. read more


Calculation of SPC term in EU accession countries

Saufung Ma discusses the recent decision of the CJEU in F. Hoffman-La Roche AG v Accord Healthcare OÜ and its impact upon the calculation of Supplementary Protection Certificate term in accession more


Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here